A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).

Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, Nomoto H, Fujisawa K, Nagashima M, Terada M, Ashida S, Morioka S, Satake M, Hangaishi A, Togano T, Shiratori K, Takamatsu Y, Maeda K, Ohmagari N, Sugiura W, Mitsuya H

Open source

DOI
10.3390/life12060856
Published
2022 Jun 8
Container
Life (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life12060856,
  title = {A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).},
  author = {Tomita N and Saito S and Terada-Hirashima J and Mikami A and Uemura Y and Kutsuna S and Nomoto H and Fujisawa K and Nagashima M and Terada M and Ashida S and Morioka S and Satake M and Hangaishi A and Togano T and Shiratori K and Takamatsu Y and Maeda K and Ohmagari N and Sugiura W and Mitsuya H},
  year = {2022},
  journal = {Life (Basel, Switzerland)},
  doi = {10.3390/life12060856},
  url = {https://doi.org/10.3390/life12060856}
}

RIS

TY  - JOUR
TI  - A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).
AU  - Tomita N
AU  - Saito S
AU  - Terada-Hirashima J
AU  - Mikami A
AU  - Uemura Y
AU  - Kutsuna S
AU  - Nomoto H
AU  - Fujisawa K
AU  - Nagashima M
AU  - Terada M
AU  - Ashida S
AU  - Morioka S
AU  - Satake M
AU  - Hangaishi A
AU  - Togano T
AU  - Shiratori K
AU  - Takamatsu Y
AU  - Maeda K
AU  - Ohmagari N
AU  - Sugiura W
AU  - Mitsuya H
PY  - 2022
JO  - Life (Basel, Switzerland)
DO  - 10.3390/life12060856
UR  - https://doi.org/10.3390/life12060856
ER  - 

APA

N, T., S, S., J, T., A, M., Y, U., S, K., H, N., K, F., M, N., M, T., S, A., S, M., M, S., A, H., T, T., K, S., Y, T., K, M., N, O., W, S., & H, M. (2022). A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).. Life (Basel, Switzerland). https://doi.org/10.3390/life12060856

Source records